Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

725
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
725
Hazard Ratio01:12

Hazard Ratio

737
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
737
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.9K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.9K
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

584
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
584
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

345
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal cord FDG PET uptake in healthy adults: an AI-driven segmentation study.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

Progression-free Survival Following Primary Staging with [<sup>18</sup>F]PSMA-1007-PET/ceCT Versus Na[<sup>18</sup>F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial.

European urology open science·2026
Same author

Quantification of Costal Cartilage Calcification Using <sup>18</sup>F-NaF-PET/CT.

Journal of imaging·2026
Same author

<sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT imaging of spinal instrumentation: case report and review of the literature.

American journal of nuclear medicine and molecular imaging·2026
Same author

Prognostic value of the SENTIREC-endo algorithm integrating sentinel lymph node and FDG-PET/CT in staging high-risk endometrial cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Valve-Sparing Aortic Root Replacement: Comparison of Long-Term Outcomes Between the David and Yacoub Procedure in Denmark.

Interdisciplinary cardiovascular and thoracic surgery·2026

Related Experiment Video

Updated: Apr 15, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.1K

Analyzing paired diagnostic studies by estimating the expected benefit.

Oke Gerke1, Poul Flemming Høilund-Carlsen, Werner Vach

  • 1Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark; Department of Business and Economics, Centre of Health Economics Research, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark.

Biometrical Journal. Biometrische Zeitschrift
|March 27, 2015
PubMed
Summary

Bridging the gap between diagnostic test performance and patient outcomes is crucial. This study proposes using "expected benefit" with statistical inference methods to formally link test characteristics to actual patient benefits, moving beyond surrogate endpoints.

Keywords:
Decision analytic modelingDiagnostic accuracy studyPatient-relevant outcomeSensitivitySpecificity

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Experiment Videos

Last Updated: Apr 15, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Area of Science:

  • Medical Diagnostics
  • Health Services Research
  • Biostatistics

Background:

  • Diagnostic research efficacy assessment often relies on surrogate endpoints like sensitivity and specificity, which may not directly reflect patient outcomes.
  • Randomized controlled trials are infrequent in diagnostic research, creating a need for alternative methods to evaluate diagnostic procedures' impact.
  • Existing informal methods to link test performance to patient outcomes lack formal statistical rigor.

Purpose of the Study:

  • To introduce and evaluate a formal statistical approach for assessing the impact of diagnostic procedures on patient outcomes.
  • To propose "expected benefit" as a quantifiable measure that bridges the gap between diagnostic test characteristics and patient-relevant outcomes.
  • To demonstrate the application of formal inference techniques for determining expected benefit using real-world data.

Main Methods:

  • Framing the "expected benefit" as an estimation problem.
  • Developing and considering two distinct approaches for statistical inference related to expected benefit.
  • Utilizing data from a prior published study to illustrate the proposed methodology.

Main Results:

  • The study demonstrates a formal method to estimate the expected benefit of diagnostic tests.
  • Application of statistical inference techniques provides insights into the relationship between test performance and patient outcomes.
  • The proposed approach offers a more direct link between diagnostic accuracy and clinical utility.

Conclusions:

  • The "expected benefit" offers a promising formal approach to evaluate diagnostic procedures, moving beyond traditional surrogate endpoints.
  • Formal statistical inference applied to expected benefit can provide valuable insights for clinical decision-making and healthcare policy.
  • This methodology enhances the evaluation of diagnostic tests by directly considering their impact on patient outcomes.